Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1230559.RAEoJc2B9Yxyc-k5-K1Z1EkyWPTpBhBkMychOxv0JHeBg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1230559.RAEoJc2B9Yxyc-k5-K1Z1EkyWPTpBhBkMychOxv0JHeBg130_assertion type Assertion NP1230559.RAEoJc2B9Yxyc-k5-K1Z1EkyWPTpBhBkMychOxv0JHeBg130_head.
- NP1230559.RAEoJc2B9Yxyc-k5-K1Z1EkyWPTpBhBkMychOxv0JHeBg130_assertion description "[Combinatorial targeting on both HER2 and STAT3 may enhance the efficacy of trastuzumab or other HER2-targeting agents in HER2-positive breast and gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1230559.RAEoJc2B9Yxyc-k5-K1Z1EkyWPTpBhBkMychOxv0JHeBg130_provenance.
- NP1230559.RAEoJc2B9Yxyc-k5-K1Z1EkyWPTpBhBkMychOxv0JHeBg130_assertion evidence source_evidence_literature NP1230559.RAEoJc2B9Yxyc-k5-K1Z1EkyWPTpBhBkMychOxv0JHeBg130_provenance.
- NP1230559.RAEoJc2B9Yxyc-k5-K1Z1EkyWPTpBhBkMychOxv0JHeBg130_assertion SIO_000772 25327561 NP1230559.RAEoJc2B9Yxyc-k5-K1Z1EkyWPTpBhBkMychOxv0JHeBg130_provenance.
- NP1230559.RAEoJc2B9Yxyc-k5-K1Z1EkyWPTpBhBkMychOxv0JHeBg130_assertion wasDerivedFrom befree-2016 NP1230559.RAEoJc2B9Yxyc-k5-K1Z1EkyWPTpBhBkMychOxv0JHeBg130_provenance.
- NP1230559.RAEoJc2B9Yxyc-k5-K1Z1EkyWPTpBhBkMychOxv0JHeBg130_assertion wasGeneratedBy ECO_0000203 NP1230559.RAEoJc2B9Yxyc-k5-K1Z1EkyWPTpBhBkMychOxv0JHeBg130_provenance.